Congenital Lung MalformationNCT07859774
Early Outcomes of Thoracoscopic Anatomical Lesion Resection for Congenital Lung Malformations in Children: A Single-Center Experience in a Limited-Resource Country
An observational study of Congenital Lung Malformation, run by Al-Azhar University.
Trial summary
This study aimed to evaluate the safety and efficacy of thoracoscopic resection for CLMs in pediatric patients. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Congenital Lung Malformation
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 30 Sep 2026to 30 Oct 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Pediatric patients
Who may be able to join
- pediatric patients underwent thoracoscopic managment of congenital lung malformations
Who cannot join
- patients underwent open thoracotomy for congenital lung malformations
- Recurrent cases
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
This study aimed to evaluate the safety and efficacy of thoracoscopic resection for CLMs in pediatric patients.
Read the detailed description
Retrospectove study of pediatric patients who underwent thoracoscopic resection for CLMs between 2023 and 2026. Demographics, clinical presentation, operative parameters, and postoperative outcomes were analyzed.
- Conditions
- Congenital Lung Malformation
- Keywords
- Thoracoscopic, Congenital lung malformation, Pediatric
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients underwent thoracoscopic managment of congemital lung malformation | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Conversion to open
Measured: One month
Secondary outcomes (1)
Postoperative complications
Measured: One month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2026
- Study start30 Sep 2026 (estimated)
- Primary completion30 Oct 2026 (estimated)
- Study completion30 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Congenital Lung MalformationStudies of the same condition, open and under way.
- More trials run by Al-Azhar UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Al-Azhar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abdelmaboud, Al-Azhar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07859774
- Sponsor's protocol ID
- Ped-Surg.256MedResearch
- Status last verified
- Sep 2026
- First submitted
- 30 Sep 2026
- Last updated
- 6 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early Outcomes of Thoracoscopic Anatomical Lesion Resection for Congenital Lung Malformations in Children: A Single-Center Experience in a Limited-Resource Country
- ClinicalTrials.gov ID
- NCT07859774
- Acronym / sponsor ID
- Ped-Surg.256MedResearch
- Conditions
- Congenital Lung Malformation
- Keywords
- Thoracoscopic, Congenital lung malformation, Pediatric
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Al-Azhar UniversityUniversity, hospital or other
- Study start
- 30 Sep 2026 (estimated)
- Primary completion
- 30 Oct 2026 (estimated)
- Study completion
- 30 Oct 2026 (estimated)
- First posted
- 6 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to evaluate the safety and efficacy of thoracoscopic resection for CLMs in pediatric patients.
Detailed description
Retrospectove study of pediatric patients who underwent thoracoscopic resection for CLMs between 2023 and 2026. Demographics, clinical presentation, operative parameters, and postoperative outcomes were analyzed.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients underwent thoracoscopic managment of congemital lung malformation | – | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Pediatric patients
Key inclusion criteria (1 listed)
- pediatric patients underwent thoracoscopic managment of congenital lung malformations
Key exclusion criteria (2 listed)
- patients underwent open thoracotomy for congenital lung malformations
- Recurrent cases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Conversion to open
Time frame: One month
1 secondary outcome
Postoperative complications
Time frame: One month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Congenital Lung Malformation
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Recruiting
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
Premature Infants, Bronchopulmonary Dysplasia
Active, not recruitingObservational study
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Cystic Fibrosis, Bone Loss
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Congenital Lung Malformation, run by Al-Azhar University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed Abdelmaboud, MD (+201012335539, drmohamedkhalifa2014@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Conversion to open (time frame: One month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.